Special Advisor to the Board
management team
ASCENEURON
Switzerland
Dr. Franz F. Hefti is President & CEO of Proclara Biosciences, a biotechnology company developing new medications for Alzheimer’s and related diseases. He previously held senior positions at several biotechnology and pharmaceutical companies, and, earlier in his career, he was Professor at the University of Southern California, where he carried out seminal research on therapeutic applications of neurotrophic factors. He received his PhD from the University of Zurich and completed his postdoctoral research at the Massachusetts Institute of Technology and the Max Planck Institute in Munich. Dr. Hefti has published extensively on topics in neuropharmacology and aging.
neuropharmacology and aging